Multi-Specific Antibodies for Cross-Neutralization of Multiple Filovirus Glycoproteins
Copyright © Targeted News Service 2024
2024-12-10
ALEXANDRIA, Virginia, Dec. 10 -- ALBERT EINSTEIN COLLEGE OF MEDICINE, Bronx, New York has been assigned a patent (No. US 12162926 B2, initially filed Sept. 28, 2021) developed by three inventors Jonathan R. Lai, Dobbs Ferry, New York; Julia Frei, Bronx, New York; and Elisabeth Nyakatura, New York, New York, for "Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins." . . .